PT  - JOURNAL ARTICLE
AU  - Kathleen A Garrison
AU  - Rajita Sinha
AU  - Marc N. Potenza
AU  - Siyuan Gao
AU  - Qinghao Liang
AU  - Cheryl Lacadie
AU  - Dustin Scheinost
TI  - Transdiagnostic connectome-based prediction of craving
AID  - 10.1101/2021.05.21.21257620
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.21.21257620
4099  - http://medrxiv.org/content/early/2021/05/25/2021.05.21.21257620.short
4100  - http://medrxiv.org/content/early/2021/05/25/2021.05.21.21257620.full
AB  - Craving is a central construct in the study of motivation and human behavior and is also a clinical symptom of substance and non-substance-related addictive disorders. Thus, craving represents a target for transdiagnostic modeling. We applied connectome-based predictive modeling (CPM) to functional connectivity data in a large (N=274) transdiagnostic sample of individuals with and without substance-use-related conditions, to predict self-reported craving. CPM is a machine-learning approach used to identify neural ‘signatures’ in functional connectivity data related to a specific phenotype. Functional connectomes were derived from three guided imagery conditions of personalized appetitive, stress, and neutral-relaxing experiences. Craving was rated before and after each imagery condition. CPM successfully predicted craving, thereby identifying a transdiagnostic ‘craving network’ comprised primarily of the posterior cingulate cortex, hippocampus, visual cortex, and primary sensory areas. Findings suggest that craving may be associated with difficulties directing attention away from internal self-related processing, represented in the default mode network.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMind and Life Institute A-36649338, R01-AA013892-15, P50-DA016556, UL1-De019586, PL1-DA024859, RL1-AA017539, R01-DK00039, R01 MH121095, R01 DA039136Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study procedures were approved by the Yale IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMatlab scripts to run the main CPM analyses can be found at https://github.com/YaleMRRC/CPM/tree/master/matlab/func/misc. BioImage Suite tools used for analysis and visualization can be accessed at www.bisweb.yale.edu.